Signaling Pathways - Ca2 -ATPases - p53-MDM2 interaction - GTPases - Insulin and Insulin-like Receptors
清除全部
- B6614 Thapsigargin1 Citation中文名: 毒胡萝卜素Target: Ca2 -ATPasesSummary: 肌质网状Ca2+-ATP酶抑制剂
- A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A2005 Nutlin-3bTarget: p53-MDM2 interactionSummary: MDM2/p53抑制剂
- A1605 Dynasore4 CitationTarget: GTPasesSummary: Dynamin(动力素)GTP酶抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂